• Prescribing Information
  • Medical Information
  • Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve.

    Click here to learn how we are responding.

    Confirmed Protection Against Diverse MenB Strains with 2 Doses1

    While you don't know which strains your patients may encounter, TRUMENBA is the ONLY MenB vaccine with confirmed evidence of diverse strain protection
    (14 strains).1*

    *Based on demonstrated effectiveness against 14 diverse strains representative of prevalent MenB strains.

    Learn more about diverse strain protection

    Pfizer TruSupport

    ​​​​​​​
    • Ordering options
    • Patient ​​​​​​​coverage confirmation
    • Essential tools
    • Resources for your practice​​​​​​​
    Find out more about TruSupport​​​​​​​
    Find out more about TruSupport

    CDC recommendations

    MenB vaccination is part of the CDC 16-year-old vaccination platform.2

    Read the recommendations

    CDC=Centers for Disease Control and Prevention.

    The science behind TRUMENBA

    Only TRUMENBA targets both subfamilies, A and B, of fHbp.1,3

    CDC=Centers for Disease Control and Prevention.

    CDC=Centers for Disease Control and Prevention.

    CDC=Centers for Disease Control and Prevention.

    See the science

    fHbp=factor H binding protein.​​​​​​​

    ** This is an optional area where footnotes can live.

    TRUMENBA clinical studies

    TRUMENBA is the only MenB vaccine that demonstrates coverage of diverse MenB strains by targeting both subfamilies, A and B, of fHbp.1,3

    See the data

    ** This is an optional area where footnotes can live.

    Contact your Pfizer Sales Representative or call a Vaccine Specialist at 
    ​​​​​​​1-844-439-2571.


    References:
    1. TRUMENBA [package insert]. Philadelphia, PA: Pfizer Inc.; 2021. 
    2. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2021. Centers for Disease Control and Prevention website. Accessed October 21, 2021. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. 
    3. Wang X, Cohn A, Comanducci M, et al. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine. 2011;29(29-30):4739-4744.

    Indication

    • Trumenba is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age
    • Severe allergic reaction (eg, anaphylaxis) to any component of Trumenba is a contraindication
    • Some individuals with altered immunocompetence may have reduced immune responses to Trumenba
    • Persons with certain complement deficiencies and persons receiving treatment that inhibits terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis serogroup B even if they develop antibodies following vaccination with Trumenba
    • Vaccination with Trumenba may not protect all vaccine recipients against N meningitidis serogroup B infections
    • Syncope (fainting) can occur in association with administration of injectable vaccines, including Trumenba. Procedures should be in place to avoid injury from fainting
    • In clinical studies, the most common solicited adverse reactions in adolescents and young adults were pain at injection site (≥85%), fatigue (≥60%), headache (≥55%), and muscle pain (≥35%) 
    • Data are not available on the safety and effectiveness of using Trumenba and other meningococcal group B vaccines interchangeably to complete the vaccination series
    • Safety and effectiveness have not been established in pregnant women
    • Trumenba is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age

    Please see full Prescribing Information.​​​​​​​